Please read this leaflet carefully before you start using TRELEGY ELLIPTA. This leaflet answers some common questions about TRELEGY ELLIPTA. It does not contain all the available information.

Medscape Publishers' Circle ® is a collection of high-quality healthcare information from prominent medical publishers, available free on Medscape.com to registered Medscape members. It includes ...

This is the story of the first 5 years of Medscape the site. It is also the story of Medscape the company that ran the site until its fifth birthday in May 2000. Most media businesses have plans ...

European regulators have refused to back GlaxoSmithKline’s daily triple therapy Trelegy Ellipta for asthma, denying a label extension because there was no evidence to show a reduction of flare-ups.

Now, it has decided to publish a special report on two of GSK's COPD therapies – Breo Ellipta (fluticasone furoate and vilanterol) and Trelegy Ellipta (fluticasone furoate, umeclidinium ...